DEF: Picard Medical Seeks Shareholder Approval for Expanded Equity Plan

Picard Medical, Inc. will hold a special meeting on October 10, 2025, to seek stockholder approval for an amendment to its 2021 Equity Incentive Plan, increasing available shares to 18 million and including warrants as award types.

Summary

• A special meeting of stockholders for Picard Medical, Inc. will be held entirely online on October 10, 2025, at 8:00 p.m. Eastern Time.
• The primary purpose of the meeting is to approve an amendment to the company's 2021 Equity Incentive Plan (the Amended Incentive Plan).
• The proposed amendment seeks to increase the aggregate number of shares of common stock available under the plan to a total of 18,000,000 shares.
• The amendment also proposes to include warrants as a type of award issuable under the Amended Incentive Plan and to ratify the existing 2021 Equity Incentive Plan.
• As of the record date, September 16, 2025, there were 73,701,176 shares of common stock outstanding and entitled to vote.
• If the proposal is approved, the total number of shares available for future awards under the plan will be 10,324,806, representing 11.26% of the fully diluted shares.
• The Board of Directors unanimously recommends a vote FOR the approval of the amendment to the 2021 Equity Incentive Plan.
• Equity awards granted as of September 26, 2025, include 2,378,124 options for the CEO, 511,195 for the CFO, and 579,803 for the COO, valued at $20,689,679, $4,447,397, and $5,044,286 respectively, based on a closing market price of $8.70.
• Major beneficial owners as of September 26, 2025, include Hunniwell Picard I, LLC with 39,618,919 shares (54.8%) and Sindex SSI Financing, LLC with 7,943,585 shares (11.0%).

Sentiment

Score: 7

Explanation: The filing outlines a routine corporate governance action aimed at strengthening employee and director incentives, which is generally viewed positively for long-term company stability and performance. The proposed changes are presented as essential for talent retention and competitive positioning.

Positives

• The amendment aims to enhance the company's ability to attract, retain, and motivate key employees, officers, directors, consultants, and advisors by providing long-term, equity-based incentives.
• Including warrants as an award type offers greater flexibility in structuring compensation packages.
• Aligns the financial interests of service providers with the long-term interests of stockholders, potentially driving increased shareholder value.

Risks

• If stockholder approval for the share increase is not obtained, there will be insufficient shares available under the plan to make annual awards and provide grants to new hires in future years.
• Failure to approve the amendment would require the company to revise its compensation philosophy and formulate other cash-based programs to attract, retain, and compensate key personnel, potentially increasing cash burn.

Future Outlook

The company expects the requested increase in the number of shares to be sufficient to provide plan awards for at least an additional year, after which stockholder approval for additional shares would be sought. The future success of the company depends on its ability to maintain a competitive position in attracting, retaining, and motivating key personnel through such incentive plans.

Management Comments

• "Your vote is very important! Whether or not you plan to attend the Special Meeting, we urge you to read the enclosed proxy statement and vote as soon as possible via the Internet, by telephone or, if you receive a paper proxy card or voting instruction form in the mail, by mailing the completed proxy card or voting instruction form. Thank you for your confidence and continued support." Patrick NJ Schnegelsberg, Chief Executive Officer and Director.

Industry Context

Equity incentive plans are a standard and critical tool across various industries, particularly in competitive sectors like medical technology, for attracting, retaining, and motivating high-caliber talent. Companies frequently adjust these plans to ensure they remain competitive with industry benchmarks for compensation and to align employee interests with long-term shareholder value creation.

Comparison to Industry Standards

• The filing emphasizes the need to maintain a 'competitive position in attracting, retaining and motivating key personnel,' implying adherence to industry standards for compensation.
• While the filing does not list specific comparable companies or projects, the proposed increase in the share reserve and the inclusion of warrants are common mechanisms used by public companies to offer flexible and attractive equity compensation in line with broader market practices.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Potential for dilution due to the increase in authorized shares for equity awards, but also potential for increased long-term value creation through better talent retention and motivation. Voting rights are exercised at the special meeting.
• **Employees, Officers, Directors, Consultants, and Advisors**: Direct positive impact through enhanced opportunities for equity-based compensation, which serves as a significant incentive and retention tool.
• **Company**: Strengthens its ability to compete for and retain key personnel, which is vital for strategic execution and operational success.

Next Steps

• Stockholders are urged to vote via Internet, telephone, or mail as soon as possible.
• The Special Meeting of Stockholders will be held online on October 10, 2025, for voting on the proposed amendment.
• Preliminary voting results will be announced at the Special Meeting.
• Final voting results will be published in a Current Report on Form 8-K filed with the SEC within four business days after the Special Meeting.

Key Dates

Keywords

Equity Incentive Plan, Stock Options, Warrants, Employee Compensation, Corporate Governance, Shareholder Meeting, Stockholder Approval, Executive Compensation, Picard Medical